Key regions: United States, Germany, Australia, India, United Kingdom
The Sleep Aids (Pharmacies) market in Australia & Oceania is experiencing steady growth, driven by increasing customer preferences for natural and non-habit forming sleep aids.
Customer preferences: Customers in Australia & Oceania are increasingly seeking sleep aids that are natural and non-habit forming. They are becoming more conscious of the potential side effects and risks associated with traditional sleep aids, such as dependency and morning grogginess. As a result, there is a growing demand for sleep aids that use herbal ingredients and have a gentle effect on the body. Customers are also looking for sleep aids that promote overall relaxation and stress relief, as these factors are often linked to sleep disturbances.
Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in Australia & Oceania is the rise of herbal sleep aids. These products are formulated with natural ingredients such as chamomile, valerian root, and lavender, which are known for their calming and sleep-inducing properties. Herbal sleep aids are gaining popularity due to their perceived safety and effectiveness. Customers are also attracted to the holistic approach of herbal sleep aids, as they often address underlying factors that contribute to sleep disturbances, such as anxiety and stress. Another trend in the market is the increasing availability of sleep aids that combine multiple ingredients to target different aspects of sleep. For example, some products may contain a combination of melatonin, a hormone that regulates sleep-wake cycles, and herbal extracts that promote relaxation. These multi-ingredient sleep aids are designed to provide a comprehensive solution to sleep problems, catering to the diverse needs of customers.
Local special circumstances: Australia & Oceania has a unique geography and climate, which can impact sleep patterns and contribute to sleep disturbances. For example, some regions experience high temperatures and humidity, which can make it difficult for individuals to fall asleep or stay asleep. This local special circumstance has led to the development of sleep aids that specifically address temperature regulation and promote a more comfortable sleep environment. These products may include cooling gel pads or moisture-wicking fabric to help regulate body temperature and improve sleep quality.
Underlying macroeconomic factors: The Sleep Aids (Pharmacies) market in Australia & Oceania is also influenced by underlying macroeconomic factors. For instance, the growing awareness and acceptance of mental health issues in society have led to increased recognition of the importance of sleep for overall well-being. As a result, there is a greater emphasis on sleep health and the use of sleep aids to address sleep disturbances. Additionally, the aging population in Australia & Oceania is driving the demand for sleep aids, as older individuals are more likely to experience sleep problems and seek solutions to improve their sleep quality. In conclusion, the Sleep Aids (Pharmacies) market in Australia & Oceania is experiencing growth due to customer preferences for natural and non-habit forming sleep aids. The market is characterized by the increasing popularity of herbal sleep aids and the availability of multi-ingredient products. Local special circumstances, such as the impact of climate on sleep patterns, have also influenced the development of sleep aids in the region. Overall, the market is driven by the growing recognition of the importance of sleep for overall well-being and the aging population in Australia & Oceania.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
